Puig has acquired a majority share of Dr. Barbara Sturm. Founder Dr. Barbara Sturm will retain a minority share and will serve as chief product development officer.

Reports circulated that the brand was up for sale last year, as reported by Happi.

The premium skincare brand was founded in 2014 and has since expanded its portfolio of products from skincare into body and haircare and supplements.

The acquisition of Dr. Barbara Sturm reinforces Puig’s competitive position in the premium skincare segment by welcoming a globally recognized luxury cult brand developed through its digital channels and worldwide spa and boutiques network, offering high-performance treatments with deep expertise in skincare, Puig announced.

In addition, Puig says it is committed to driving the brand’s international expansion and development and building on its existing network of spas and boutiques across Düsseldorf, London, New York, Miami, Los Angeles, Dallas, Jakarta and Singapore.

“We are very excited to welcome a brand of the caliber of Dr. Barbara Sturm… With its science-focused skincare product range and high-performance treatments, we are taking another important step in expanding our position in the premium skincare segment. The new partnership reinforces Puig skincare segment and our presence in the US,” Marc Puig, chairman and CEO, said in a statement.

In 2002, Dr. Sturm translated the science from her clinical research and orthopaedic practice into the world of aesthetics with her MCX treatment, a Platelet-Rich Plasma now known as the “Blood Facial.” She followed this with the launch of her MC1 cream (Molecular Cosmetics Cream), a plasma-based moisturizer that uses the power of the body’s own proteins to heal the skin.

Additional Reading